Powder Delivery TRIZ Cases

A nicotine pouch filler with 6 to 10 wt% binder maintains structural integrity while ensuring consistent nicotine release.

Polyacetal polymers with pH-sensitive linkages localize therapeutic agents in tumor microenvironments, reducing adverse effects on non-target tissues.

Characterized stable crystalline forms resolve manufacturing and stability bottlenecks for tablet development.

Manganese dioxide oxidation simplifies synthesis steps, reduces impurities, and ensures high-purity Form A crystals for respiratory treatments.

A pouch-like structure composed of engineered tissue with genetically modified cells releases paracrine factors to support heart function.

Cannabidiol cocrystals combine the active ingredient with specific coformers to resolve solubility and stability limitations in therapeutic delivery.

Segments insulin secretion via GPR40 activation alongside DPP-4 inhibition to prevent hypoglycemia and weight gain.

Conjugating proteolytic enzymes to liposome surfaces overcomes stratum corneum permeability limits while minimizing skin irritation.

Calcium-containing agents activate synthetic heparin-binding growth factor analogs, resolving the lack of delivery methods for osteogenic defects.

A dry powder formulation uses fine and coarse alpha-lactose monohydrate particles with formoterol fumarate and beclometasone dipropionate.

High shear mixing reduces ivermectin particle size while antioxidants prevent air oxidation.

An oral ingestible composition combines spore-forming probiotics with L-arginine to stabilize gut microbiota and enhance mucosal barrier integrity.

Spray coating sodium picosulfate onto potassium bicarbonate granules creates a uniform coated layer structure for pharmaceutical manufacturing.

Divalent cations stabilize oxytocin disulfide bridges, preventing dimer formation and enabling heat-stable dry powder delivery without refrigeration.

Fibrinogen-coated albumin nanospheres mobilize hematopoietic stem cells to repair non-union fractures without surgical immobilization.

A respiratory spray uses a film-forming agent to coat the throat and provide on-demand cough relief.

Polyglyceryl ester surfactants reduce viscosity in aqueous peroxide dispersions, preventing thick paste formation during milling and maintaining pumpability.

Megasphaera massiliensis compositions reduce inflammation and oxidative stress to protect neurons.

Memantine resin complex uses osmotic coating to prevent dose dumping caused by ion concentration variability.

Aldol-crosslinked polymeric hydrogel adhesive joins biological tissue via covalent bonding between oxidized polysaccharides and acetoacetate-functionalized poly(hydroxylic) compounds.

Cationic nanoparticles solubilize lyophilized antigens in aqueous media, eliminating undesirable additives and enabling rapid vaccine preparation.

Chelating agents complex iron species in ranitidine compositions to prevent N-nitrosodimethylamine formation during processing.

2-deoxyglucose-functionalized magnetic nanoparticles provide enhanced contrast for detecting diseased tissues.

Silicate nanoparticles induce human mesenchymal stem cells to differentiate into chondrocytes through clathrin-mediated endocytosis and intracellular ionic dissolution.

Alternating charged layers stabilize modified circumsporozoite protein antigens, resolving vaccine efficacy limits while maintaining production scalability.

A lyophilized formulation of stem cell-derived exosomes stabilizes biological activity through freeze-drying with protective excipients.

Optimized activated charcoal with controlled particle size adsorbs fat and cholesterol in the intestine, preventing nutrient malnutrition.

Trehalose preserves TLR9-adjuvanted heroin vaccine stability at room temperature, preventing degradation while maintaining lethal dose protection.

Optimized hydroxyalkyl alkyl cellulose resolves HPMC compressibility limits by balancing fibrous content to prevent tableting failures.

A resuscitative fluid composition restores intravascular volume and pressure using specific salts, saccharides, and hydrophilic polymers.

Porous silicon carriers protect antibodies from proteolytic degradation in wounds, maintaining efficacy while reducing systemic toxicity.

A biodegradable microrobot integrates magnetic nanoparticles and living cells to enable precise, wireless drug transport within the body.

Avidin-biotin linkages functionalize silk fibroin to preserve bioactivity lost during direct covalent coupling, enabling targeted biomedical delivery.

Amorphous solid dispersions of bradykinin B2 receptor antagonists in HPMCAS or copovidone polymers improve bioavailability by overcoming poor solubility.

Direct preparation of anhydrous tiotropium bromide using specific solvent combinations and chemical drying agents to ensure high purity.

Gold nanocluster radiotracers target natriuretic peptide receptors, reducing blood retention time and enabling earlier imaging.

Nanoparticle encapsulation of superoxide dismutase and catalase sustains release at the injury site, resolving oxidative stress that limits spinal cord repair.

Replacing turbulent mixing, a packed bed emulsifier enforces laminar flow to stabilize microparticle size distribution and enable scalable production.

Measuring bulk protein concentration before filling allows dynamic adjustment of fill weight to maintain consistent post-reconstitution dosage.

Buffering salts adjust pH between 5-8 to prevent phase separation and clumping when combining choline bitartrate with milk proteins in solid powders.

Cell-penetrating peptides enable saporin nanocomplexes to overcome low cell permeability and deliver ribosome-inactivating proteins effectively.

Organic matrices disperse inorganic nanoparticles to prevent agglomeration and enable scalable commercial production.

Porous excipients load active agents inside their pores, reducing formulation volume while maintaining stability.

Cyclodextrin complexes improve lauric acid solubility and metabolic stability to inhibit gram-positive and gram-negative bacteria.

A cross-linked bioactive hydrogel matrix retains adherent cells during cryopreservation, eliminating mechanical detachment damage and re-culturing steps.

Serum-free culture and albumin stabilization resolve purity and stability trade-offs in MSC-EV manufacturing.